1-8 of 8
Claire N. Harrison, BMBCh, DM, FRCP, FRCPath
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from the 208-Week (4-Year) Follow-up of RESPONSE Trial, a Phase 3 Study Comparing Ruxolitinib (Rux) with Best Available Therapy (BAT) for the Treatment of Polycythemia Vera (PV)

Jean-Jacques Kiladjian, MD PhD, Srdan Verstovsek, MD PhD, Martin Griesshammer, Tamás Masszi, MD Prof., Simon Durrant, FRCP,FRCPath,MBBS, Francesco Passamonti, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Fabrizio Pane, MD, Pierre Zachee, MD PhD, Keita Kirito, MD, Carlos Besses, MD PhD, Masayuki Hino, MDPhD, Ana Ines Varela, Carole B. Miller, MD, Elisa Rumi, MD, Vittorio Rosti, MD, Igor Wolfgang Blau, MD, Ruben A Mesa, MD, Tuochuan Dong, Nathalie Francillard, Mary Laughlin, Alessandro M. Vannucchi
Journal: Blood
Blood (2017) 130 (Supplement 1): 322.
https://doi.org/10.1182/blood.V130.Suppl_1.322.322
Published: 2017
Journal Articles

Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial

Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Peter J Campbell, MD PhD, Cathy MacLean, BSc, MSc, MBA, Georgina Buck, BSc, MSc, Clare L. East, BSc, Julia Cook, BSc, Julie Temple, BSc, Bridget S. Wilkins, MD FRCPath, Keith Wheatley, DPhil, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Mary Frances Frances McMullin, MB,Bch BAO, MD FRCPath, Cecily Forsyth, MB BS, Jean-Jacques Kiladjian, MD PhD, Anthony R. Green, FRCP, FRCPath, FMed Sci, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 319.
https://doi.org/10.1182/blood.V130.Suppl_1.319.319
Published: 2017
Journal Articles

Psychostimulant Use Among Myeloproloferative Neoplasm Patients

Robyn M. Scherber, MD, Blake T. Langlais, Heidi Elizabeth Kosiorek, MS, Amylou Dueck, PhD, Holly Geyer, MD, Zhenya Senyak, Archie McCallister, MD, Mary Cotter, MA, Barbara VanHusen, Jeanne Palmer, MD, Leslie Padrnos, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Angela G. Fleischman, MD PhD, Ruben A Mesa, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5657.
https://doi.org/10.1182/blood.V130.Suppl_1.5657.5657
Published: 2017
Journal Articles

Case Series of Potential Wernicke's Encephalopathy in Patients Treated with Fedratinib

Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Ruben A Mesa, MD, Catriona Jamieson, MD PhD, John Hood, PhD, Julie Bykowski, MD, Giulio Zuccoli, MD, James Brewer, MD,PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4197.
https://doi.org/10.1182/blood.V130.Suppl_1.4197.4197
Published: 2017
Journal Articles

Myeloproliferative Neoplasms and Depressive Symptoms, Diagnosis, and Associations

Leslie Padrnos, MD, Robyn M. Scherber, MD, Blake T. Langlais, Amylou Dueck, PhD, Jennifer Huberty, PhD, Holly L. Geyer, MD, Krisstina L. Gowin, DO, Heidi Kosiorek, MS, Marlene Bruso, MS, Zhenya Senyak, MA, Matthew M Clark, PhD, Michael Boxer, MD, Mary Cotter, MA, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Ruben A Mesa, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2161.
https://doi.org/10.1182/blood.V130.Suppl_1.2161.2161
Published: 2017
Journal Articles

A Phase Ib Study to Assess the Safety and Tolerability of Ruxolitinib in Combination with Azacitidine in Patients with Advanced Phase Myeloproliferative Neoplasms (MPN), Including Myelodysplastic Syndromes (MDS) or Acute Myeloid Leukaemia (AML) Arising from MPN (The Bloodwise / TAP PHAZAR Study on Behalf of the UK MPN CSG)

Mark W Drummond, MB ChB, PhD FRCPath, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Samuel Munoz Vicente, MSc, Adam J Mead, MD PhD, Christina Yap, MSci, PhD CStat, Frederick Chen, FRCP, FRCPath, PhD, Srinivasan Narayanan, MBBS, MRCP, FRCPath, Dragana Milojkovic, MBBS, PhD, Leyre Navarro-Nunez, PhD, Steven Knapper, BMBCh, MRCP, MRCPath, DM
Journal: Blood
Blood (2017) 130 (Supplement 1): 1649.
https://doi.org/10.1182/blood.V130.Suppl_1.1649.1649
Published: 2017
Journal Articles

Ruxolitinib Induces Changes in Histone Modification Status in Patients Entered into the Majic Clinical Trial

Suzanne McPherson, MB Bch BAO MRCPUK FRCPath Part 1, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Adam J Mead, MD PhD, Ken I Mills, BSc PhDFRCPath, Mary Frances McMullin, MB,Bch BAO, MD FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 5285.
https://doi.org/10.1182/blood.V130.Suppl_1.5285.5285
Published: 2017
Journal Articles

Personalized Prognostic Predictions for Patients with Myeloproliferative Neoplasms through Integration of Comprehensive Genomic and Clinical Information

Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, E Joanna Baxter, PhD, Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Paola Guglielmelli, MD PhD, Rob Cantrill, PhD, David Wedge, PhD, Nicos Angelopoulos, PhD, Gunes Gundem, PhD, Charlie Massie, PhD, Elli Papaemmanuil, PhD, Cathy MacLean, BSc, MSc, MBA, Julia Cook, BSc, Francesca Lauren Nice, PhD MSc, Christen Lykkegaard Andersen, PhD, Hans Carl Hasselbalch, MD Professor, DMSc, Mary Frances McMullin, MB,Bch BAO, MD FRCPath, Alessandro M. Vannucchi, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Moritz Gerstung, PhD, Peter J Campbell, MD PhD, Anthony R Green, PhD FRCP, FRCPath, FMedSci
Journal: Blood
Blood (2017) 130 (Supplement 1): 491.
https://doi.org/10.1182/blood.V130.Suppl_1.491.491
Published: 2017